Atlas Trials

Anti-thymocyte Globulin and Melphalan in Treating Patients With Relapsed Multiple Myeloma

Clinical trial NCT00635024 · TERMINATED

Trial details

NCT number
NCT00635024
Sponsor
Mayo Clinic
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma and Plasma Cell Neoplasm
Start date
2008-05-01
Primary completion
2008-07-01
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.